Drug developer PharmaEngine Inc (智擎生技) said its French partner Nanobiotix SA has received European market approval for PEP503 (NBTXR3), enabling commercialization of the nanoparticle radio-enhancer in the EU for the treatment of locally advanced soft-tissue sarcoma.
PEP503 would be marketed in the 27 EU countries under the brand name Hensify, PharmaEngine said in a filing with the Taiwan Stock Exchange on Saturday.
PharmaEngine in August 2012 acquired the exclusive rights from Nanobiotix to develop and commercialize PEP503 in the Asia-Pacific region.
PharmaEngine might be able to license the treatment to other companies in the region in the near term, the Chinese-language Commercial Times reported yesterday, adding that royalty revenue from sales could start from US$200 million.
PEP503 is a nanoparticle formulation of crystalline hafnium oxide that was designed to enhance the efficacy of radiotherapy for cancer treatment, the company said.
In addition to the treatment of soft-tissue sarcoma, PEP503 is being evaluated for other cancer types, such as head-and-neck cancer, liver cancer, rectal cancer and prostate cancer, PharmaEngine said.
In the US, the treatment has gained approval for a clinical trial in combination with anti-PD-1 immunotherapies for patients of non-small-cell lung cancer and head-and-neck cancer, the company said.
PharmaEngine reported cumulative revenue of NT$61.04 million (US$1.98 million) for the first two months of the year, up 96.29 percent from NT$31.1 million the previous year, a company regulatory filing showed.
The surge in revenue was mainly due to contributions from its pancreatic cancer drug, Onivyde, which has received reimbursements of NT$26,400 per vial from the National Health Insurance Administration since August last year.
The company posted net profit of NT$129.36 million for last year, or NT$0.88 in earnings per share, compared with the year-earlier level of NT$387.06 million, or NT$2.62 per share.
TECH CORRIDOR: The new Phase II site is expected to work with other facilities in the region and nation as TSMC looks to shape the future with its manufacturing Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) would build three additional advanced packaging facilities in Phase II of the Chiayi Science Park (嘉義科學園區), National Science and Technology Council (NSTC) Minister Wu Cheng-wen (吳誠文) said yesterday. Speaking at the groundbreaking ceremony for the Phase II, Wu said the roughly 90-hectare site would be developed into an advanced packaging industry cluster led by TSMC. Two advanced packaging facilities at Phase I began mass production last month. Wu said that the Phase II development of the Chiayi Science Park would strengthen the resilience of the regional economy and help transform Chiayi County into a global production
Chinese authorities have held meetings with top tech firms over the past month about potentially restricting overseas access to China’s most advanced AI models, including those yet to be released, three people familiar with the discussions said. The talks follow a number of steps by Beijing to keep homegrown AI technology in the country and underscore how China, like the US, is now treating cutting-edge artificial intelligence as a critical national asset that needs controls. Companies present at the talks included tech giants Alibaba Group Holding Ltd (阿里巴巴) and ByteDance Ltd (字節跳動), as well as start-up Z.ai, formerly known as Zhipu AI
MOMENTUM: Second-quarter revenue reached NT$1.27 trillion as the June turnover surged, while TSMC’s 2nm process spending and US expansion remain focus points Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday reported its highest quarterly sales amid strong global demand for artificial intelligence (AI) applications. The world’s largest contract chipmaker posted NT$1.27 trillion (US$39.5 billion) in consolidated revenue for the second quarter of this year, up 36 percent year-on-year and nearly 12 percent from a quarter earlier. The quarterly figure was bolstered by a very strong performance last month, when TSMC’s revenue was up 67.9 percent from a year earlier and rose 6.2 percent from a month earlier to NT$442.68 billion, a new monthly high, TSMC said in a statement. At its earnings conference in April, TSMC
People buy mangoes at a wholesale market in Tainan’s Yujing District yesterday after Typhoon Bavi moved away from Taiwan. With the Irwin mango harvest season nearing its end, reduced output and strong demand has led the average mango price to climb to NT$67.4 per kg from about NT$35 at the beginning of this month, the Tainan Agriculture Bureau said.
RSS